News | January 13, 2010

Proton Therapy Offers New Specialty for Radiation Therapists

University of Texas M.D. Anderson Cancer Centers Proton Therapy Center.

January 13, 2010 – There is growing awareness about the advantages of proton therapy compared to conventional photon radiation therapy, especially when treating pediatric patients. Protons release most of their energy when they hit the tumor and deliver no exit dose beyond the tumor boundary, unlike photons. This enables the dose to better conform to the tumor and minimizes damage to healthy surrounding tissue, and enabling the radiation oncologist can potentially deliver an even greater dose. This less damaging deliver of dos is especially important when treating children by reducing radiation to growing and developing tissues.

As the proton therapy becomes more prevalent, the first proton-certified radiation therapists (RTTs) in the U.S. received advanced proton therapy certificates was notable. The RTTs earned their certificates at the Ivy Tech Community College-Bloomington program, which provides 16 college credits or the equivalent of two years of continuing education (CE) credits from the American Registry of Radiologic Technologists (ARRT). A portion of the program was held at the ProCure Training and Development Center in Bloomington, a training facility dedicated to proton therapy.

More specialized training in the field will be needed as more proton therapy spring up. Procure, a proton therapy center development company, is currently building a network of proton therapy treatment facilities across the United States. Construction is under way on a ProCure facility in suburban Chicago. Additional centers are in development in suburban Detroit, Mich., South Florida, Seattle, Wash., and Somerset, N.J.

For more information: www.ivytech.edu/bloomington and www.procure.com

Related Content

DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software
Technology | Information Technology | June 20, 2019
DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet...
New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at